業績

公益財団法人 福田記念医療技術振興財団　論文等表彰事業　優秀賞　亀田　玲奈先生

Modern Rheumatology Case Reports Top Reviewer Award 2021　加藤　将先生

Ryo Hisada, Nobuya Yoshida, Seo Yeon K. Orite, Masataka Umeda, Catalina Burbano, Marc Scherlinger, Michihito Kono, Suzanne Krishfield, and George C. Tsokos Glutaminase 2 Promotes Interleukin-2 Production in CD4+ T cells by Supporting Antioxidant Defense Arthritis Rheumatol. in press IF = 10.995

Kuniyuki Aso, Masaru Kato, Tatsuya Atsumi Axial spondyloarthritis in diffuse idiopathic skeletal hyperostosis The Journal of Rheumatology, in press

IF: 4.666

Takeuchi S, Kawakami T, Okano T, Shida H, Nakazawa D, Tomaru U, Ishizu A, Kadono T.

Elevated Myeloperoxidase-DNA Complex Levels in Sera of Patients with IgA Vasculitis.

Pathobiology. 2022;89(1):23-28.

IF: 4.342

Shibayama Y, Alkhoury C, Nemazanyy I, Henneman N, Cagnard N, Girard M, Atsumi T, Panasyuk G.

Class 3 Phosphatidyl Inositol-3 Kinase Promotes Hepatic Glucocorticoid Receptor Stability and Transcriptional Activity Acta Physiologica, in press

IF: 6.311

Satoka Shiratori-Aso, Daigo Nakazawa, Saori Nishio, Yusho Ueda, Mina Eguchi, Ai Yokoyama, Junpei Yoshikawa, Takashi Kudo, Kanako Watanabe-Kusunoki, Sayo Takeda-Otera, Junya Yamamoto, Naoko Matsuoka, Nobuharu Kaneshima, Fumihiko Hattanda, Sari Iwasaki, Takahiro Tsuji, Yuichiro Fukasawa, Tatsuya Atsumi.

Soluble interleukin-2 receptor predicts treatment outcome in patients with autoimmune tubulointerstitial nephritis. A preliminary study Frontiers in Medicine, in press.

IF 5.091

Kuniyuki Aso, Michihito Kono, Nobuya Abe, Yuichiro Fujieda, Masaru Kato, Tatsuya Atsumi Anti-ganglionic nicotinic acetylcholine receptor α3 subunit antibody as a potential biomarker associated with lupus enteritis Modern Rheumatology, in press

IF: 3.023

Shuhei Takeyama, Nobuya Abe, Tatsuya Atsumi.

Autosplenectomy.

European Journal of Internal Medicine 2022, in press.

IF 4.624

Yuki Oe, Hiroshi Nomoto, Akinobu Nakamura, Saki Kuwabara, Yuka Takahashi, Ayano Yasui, Rimi Izumihara, Aika Miya, Hiraku Kameda, Kyu Yong Cho, Tatsuya Atsumi, Hideaki Miyoshi Switching from insulin degludec plus dipeptidyl peptidase-4 inhibitor to insulin degludec/liraglutide improves glycemic variability in patients with type 2 diabetes: a preliminary prospective observation study J Diabetes Res, in press.

IF: 4.011